Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis.
Gaël VermeerschPiet MaesGéraldine LensKim C M van der ElstDietmar Rudolf ThalSander JentjensPhilippe DemaerelTine Van NieuwenhuyseElke WollantsNancy BoeckxNicolas VerhaertBenedicte DuboisFrank J M KuppeveldF J S H Sherida Woei-A-JinPublished in: European journal of neurology (2022)
In this report of a patient with rituximab-associated chronic echovirus 13 meningoencephalitis, viral clearance in response to single treatment options is assessed for the first time. Our observations further support the in vivo efficacy of fluoxetine against enteroviral infections. More research is needed to establish its efficacy in different enterovirus strains.